Search Results

C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.

• Authors : Magnusen AF; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.; Rani R

Subjects: Disease Models, Animal*; CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/*immunology ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2021 Nov 24; Vol. 22 (23). Date of Electronic Publication: 2021 Nov 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment.

• Authors : Qu Y; Cancer Immunology Discovery, Pfizer, Inc., 10777 Science Center Drive, San Diego, CA 92021, USA.; Wen J

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*pharmacology ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*metabolism ; Inflammation/Inflammation/Inflammation/*pathology

• Source: Cell reports [Cell Rep] 2020 Jul 07; Vol. 32 (1), pp. 107873.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247

Record details

Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

• Authors : McIlwrath SL; Department of Physiology, College of Medicine, University of Kentucky, Lexington, USA.; Nesemeier R

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*therapeutic use ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*metabolism ; Chemokines/Chemokines/Chemokines/*chemistry

• Source: European journal of pain (London, England) [Eur J Pain] 2017 Aug; Vol. 21 (7), pp. 1209-1223. Date of Electronic Publication: 2017 Mar 20.Publisher: Wiley Country of Publication: England NLM ID: 9801774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2149

Record details

Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis.

• Authors : Wenzel J; Department of Dermatology, University of Bonn, Bonn, Germany. ; Peters B

Subjects: Gene Expression Profiling*; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*physiology ; Dermatitis, Atopic/Dermatitis, Atopic/Dermatitis, Atopic/*diagnosis

• Source: The Journal of investigative dermatology [J Invest Dermatol] 2008 Jan; Vol. 128 (1), pp. 67-78. Date of Electronic Publication: 2007 Aug 16.Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

• Authors : Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD (MSS, HAK, AH, RMP, EAE, NEC, AKC); HPV Immunology Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD (MW, TJK, LAP). .

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; C-Reactive Protein/C-Reactive Protein/C-Reactive Protein/*metabolism ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*blood

• Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Jul 28; Vol. 107 (10). Date of Electronic Publication: 2015 Jul 28 (Print Publication: 2015).Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet

Record details

Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.

• Authors : Seo, Da Hea; Corr, Maripat; Patel, Sheena

Subjects: MORTALITY risk factors; CHEMOKINES; RISK assessment

• Source: Osteoporosis International; Oct2024, Vol. 35 Issue 10, p1789-1796, 8p

Record details

New G-Protein-Coupled Receptors Study Findings Recently Were Reported by Researchers at University of California Davis (Chemokine Cxcl9, a Marker of Inflammaging, Is Associated With Changes of Muscle Strength and Mortality In Older Men).

Subjects: OLDER men; MUSCLE strength; RESEARCH personnelDAVIS (Calif.)

• Source: Health & Medicine Week; 2024, p3291-3291, 1p

Record details

Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.

• Authors : Won KD; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Department of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Subjects: Platelet Activating Factor*/Platelet Activating Factor*/Platelet Activating Factor*/immunology ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/immunology ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy

• Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2024 May 15; Vol. 212 (10), pp. 1531-1539.Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet

Record details

Targeting interferon-γ in hyperinflammation: opportunities and challenges.

• Authors : De Benedetti F; Division of Rheumatology and Laboratory of ImmunoRheumatology, Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy. .; Prencipe G

Subjects: Immune System Diseases/Immune System Diseases/Immune System Diseases/*immunology ; Inflammation/Inflammation/Inflammation/*immunology ; Interferon-gamma/Interferon-gamma/Interferon-gamma/*antagonists & inhibitors

• Source: Nature reviews. Rheumatology [Nat Rev Rheumatol] 2021 Nov; Vol. 17 (11), pp. 678-691. Date of Electronic Publication: 2021 Oct 05.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101500080 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.

• Authors : Chen Q; Department of Laboratory Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Yu B

Subjects: Convalescence*; COVID-19/COVID-19/COVID-19/*blood ; COVID-19/COVID-19/COVID-19/*immunology

• Source: International immunopharmacology [Int Immunopharmacol] 2021 Aug; Vol. 97, pp. 107685. Date of Electronic Publication: 2021 Apr 17.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details